Clinical trial
Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat…
NCT00148018 · University of Cologne, Other · Terminated
Key facts
| NCT number | NCT00148018 |
|---|---|
| Title | Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma |
| Official title | A Phase II Study of Bortezomib in Combination With Dexamethasone in Patients With Relapsed Hodgkin's Lymphoma |
| Lead sponsor | University of Cologne, Other |
| Collaborators | German Hodgkin's Lymphoma Study Group Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hodgkin Disease |
| Intervention type | Drug |
| Interventions | Bortezomib, Dexamethasone |
| Enrollment | 37 |
| Start date | Mar 1, 2005 |
| First posted | Sep 7, 2005 |
| Last update posted | Jul 10, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: